Should we use nintedanib as early therapy in patients with SSc-ILD?

Zanatta, ElisabettaMoccaldi, BeatriceSzűcs, GabriellaSpagnolo, Paolo2023-10-162023-10-162024Autoimmunity Reviews. -23 : 1 (2024), p. 1-4. -(cikkazonosító)103463. -Autoimmun. Rev. - 1568-99721568-9972https://hdl.handle.net/2437/359792Should we use nintedanib as early therapy in patients with SSc-ILD?folyóiratcikkopen access articlehttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM115339OrvostudományokKlinikai orvostudományokhttps://linkinghub.elsevier.com/retrieve/pii/S1568997223001970http://dx.doi.org/10.1016/j.autrev.2023.1034632023-10-1600122532820000185174452529